Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Larimar Therapeutics (LRMR) Amortization of Deferred Charges: 2014-2017

Historic Amortization of Deferred Charges for Larimar Therapeutics (LRMR) over the last 3 years, with Sep 2017 value amounting to $3,000.

  • Larimar Therapeutics' Amortization of Deferred Charges fell 66.67% to $3,000 in Q3 2017 from the same period last year, while for Sep 2017 it was $23,000, marking a year-over-year decrease of 51.06%. This contributed to the annual value of $13,000 for FY2017, which is 69.77% down from last year.
  • According to the latest figures from Q3 2017, Larimar Therapeutics' Amortization of Deferred Charges is $3,000, which was down 0.00% from $3,000 recorded in Q2 2017.
  • Larimar Therapeutics' 5-year Amortization of Deferred Charges high stood at $17,000 for Q3 2014, and its period low was $3,000 during Q2 2017.
  • In the last 3 years, Larimar Therapeutics' Amortization of Deferred Charges had a median value of $11,000 in 2016 and averaged $10,727.
  • Per our database at Business Quant, Larimar Therapeutics' Amortization of Deferred Charges surged by 40.00% in 2015 and then tumbled by 72.73% in 2017.
  • Quarterly analysis of 4 years shows Larimar Therapeutics' Amortization of Deferred Charges stood at $10,000 in 2014, then skyrocketed by 40.00% to $14,000 in 2015, then fell by 28.57% to $10,000 in 2016, then crashed by 66.67% to $3,000 in 2017.
  • Its last three reported values are $3,000 in Q3 2017, $3,000 for Q2 2017, and $7,000 during Q1 2017.